Perakakis, N.; Chrysafi, P.; Feigh, M.; Veidal, S.S.; Mantzoros, C.S.
Empagliflozin Improves Metabolic and Hepatic Outcomes in a Non-Diabetic Obese Biopsy-Proven Mouse Model of Advanced NASH. Int. J. Mol. Sci. 2021, 22, 6332.
https://doi.org/10.3390/ijms22126332
AMA Style
Perakakis N, Chrysafi P, Feigh M, Veidal SS, Mantzoros CS.
Empagliflozin Improves Metabolic and Hepatic Outcomes in a Non-Diabetic Obese Biopsy-Proven Mouse Model of Advanced NASH. International Journal of Molecular Sciences. 2021; 22(12):6332.
https://doi.org/10.3390/ijms22126332
Chicago/Turabian Style
Perakakis, Nikolaos, Pavlina Chrysafi, Michael Feigh, Sanne Skovgard Veidal, and Christos S. Mantzoros.
2021. "Empagliflozin Improves Metabolic and Hepatic Outcomes in a Non-Diabetic Obese Biopsy-Proven Mouse Model of Advanced NASH" International Journal of Molecular Sciences 22, no. 12: 6332.
https://doi.org/10.3390/ijms22126332
APA Style
Perakakis, N., Chrysafi, P., Feigh, M., Veidal, S. S., & Mantzoros, C. S.
(2021). Empagliflozin Improves Metabolic and Hepatic Outcomes in a Non-Diabetic Obese Biopsy-Proven Mouse Model of Advanced NASH. International Journal of Molecular Sciences, 22(12), 6332.
https://doi.org/10.3390/ijms22126332